Pulse Biosciences Inc (NASDAQ:PLSE) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $10.29 and last traded at $10.42, with a volume of 598 shares traded. The stock had previously closed at $10.81.
PLSE has been the subject of several research reports. ValuEngine upgraded Pulse Biosciences from a “hold” rating to a “buy” rating in a research report on Thursday, September 13th. BidaskClub upgraded Pulse Biosciences from a “sell” rating to a “hold” rating in a research report on Wednesday, July 4th.
Pulse Biosciences (NASDAQ:PLSE) last issued its quarterly earnings results on Tuesday, July 31st. The company reported ($0.54) earnings per share for the quarter.
Pulse Biosciences Company Profile (NASDAQ:PLSE)
Pulse Biosciences, Inc, a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications.
Recommended Story: How accurate is the Rule of 72?
Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.